ZAK expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.97470945046052E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.9609209769369E-12 |
Normal-vs-Stage2 |
4.35420000000075E-05 |
Normal-vs-Stage3 |
1.20760001998121E-09 |
Normal-vs-Stage4 |
4.49590000000111E-05 |
Stage1-vs-Stage2 |
4.435400E-01 |
Stage1-vs-Stage3 |
8.846200E-01 |
Stage1-vs-Stage4 |
7.975200E-01 |
Stage2-vs-Stage3 |
4.483000E-01 |
Stage2-vs-Stage4 |
4.849200E-01 |
Stage3-vs-Stage4 |
8.698800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.83064674530442E-12 |
Normal-vs-AfricanAmerican |
2.288300E-02 |
Normal-vs-Asian |
8.960100E-03 |
Caucasian-vs-AfricanAmerican |
1.123710E-03 |
Caucasian-vs-Asian |
9.170400E-01 |
AfricanAmerican-vs-Asian |
1.942200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.460898234664E-12 |
Normal-vs-Female |
7.52339968101978E-10 |
Male-vs-Female |
3.110600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.79660000002124E-06 |
Normal-vs-Age(41-60Yrs) |
2.85604873084822E-12 |
Normal-vs-Age(61-80Yrs) |
1.43010003839095E-09 |
Normal-vs-Age(81-100Yrs) |
1.095880E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.614600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.752400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.428380E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.434400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.232020E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.519400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.915410E-03 |
Normal-vs-Grade 2 |
4.29745128371906E-12 |
Normal-vs-Grade 3 |
3.59849999798101E-08 |
Normal-vs-Grade 4 |
3.03020000003151E-06 |
Grade 1-vs-Grade 2 |
6.426600E-01 |
Grade 1-vs-Grade 3 |
8.004800E-01 |
Grade 1-vs-Grade 4 |
3.416800E-01 |
Grade 2-vs-Grade 3 |
3.708500E-02 |
Grade 2-vs-Grade 4 |
4.929400E-01 |
Grade 3-vs-Grade 4 |
9.431900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.19600004847109E-09 |
Normal-vs-ccB subtype |
1.33226762955019E-15 |
ccA subtype-vs-ccB subtype |
3.150400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.44440040325844E-11 |
Normal-vs-N1 |
9.407600E-04 |
N0-vs-N1 |
8.685000E-01 |
|
|